Compile Data Set for Download or QSAR
Report error Found 117 Enz. Inhib. hit(s) with all data for entry = 12701
TargetEndothelial PAS domain-containing protein 1(Human)
Novartis

US Patent
LigandPNGBDBM720904(US12226405, Example 1)
Affinity DataIC50: 3nMAssay Description:The scintillation proximal assay (SPA) was based on a competition binding assay with the radio-ligand N-(3-chloro-5-fluorophenyl-4-t)-4-nitrobenzo[c]...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/17/2025
Entry Details
Go to US Patent

TargetEndothelial PAS domain-containing protein 1(Human)
Novartis

US Patent
LigandPNGBDBM720910(US12226405, Example 7)
Affinity DataIC50: 3nMAssay Description:The scintillation proximal assay (SPA) was based on a competition binding assay with the radio-ligand N-(3-chloro-5-fluorophenyl-4-t)-4-nitrobenzo[c]...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/17/2025
Entry Details
Go to US Patent

TargetEndothelial PAS domain-containing protein 1(Human)
Novartis

US Patent
LigandPNGBDBM720914(US12226405, Example 11)
Affinity DataIC50: 3nMAssay Description:The scintillation proximal assay (SPA) was based on a competition binding assay with the radio-ligand N-(3-chloro-5-fluorophenyl-4-t)-4-nitrobenzo[c]...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/17/2025
Entry Details
Go to US Patent

TargetEndothelial PAS domain-containing protein 1(Human)
Novartis

US Patent
LigandPNGBDBM720968(US12226405, Example 65)
Affinity DataIC50: 3nMAssay Description:The scintillation proximal assay (SPA) was based on a competition binding assay with the radio-ligand N-(3-chloro-5-fluorophenyl-4-t)-4-nitrobenzo[c]...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/17/2025
Entry Details
Go to US Patent

TargetEndothelial PAS domain-containing protein 1(Human)
Novartis

US Patent
LigandPNGBDBM720980(US12226405, Example 77)
Affinity DataIC50: 3nMAssay Description:The scintillation proximal assay (SPA) was based on a competition binding assay with the radio-ligand N-(3-chloro-5-fluorophenyl-4-t)-4-nitrobenzo[c]...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/17/2025
Entry Details
Go to US Patent

TargetEndothelial PAS domain-containing protein 1(Human)
Novartis

US Patent
LigandPNGBDBM720985(US12226405, Example 82)
Affinity DataIC50: 3nMAssay Description:The scintillation proximal assay (SPA) was based on a competition binding assay with the radio-ligand N-(3-chloro-5-fluorophenyl-4-t)-4-nitrobenzo[c]...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/17/2025
Entry Details
Go to US Patent

TargetEndothelial PAS domain-containing protein 1(Human)
Novartis

US Patent
LigandPNGBDBM720987(US12226405, Example 84)
Affinity DataIC50: 3nMAssay Description:The scintillation proximal assay (SPA) was based on a competition binding assay with the radio-ligand N-(3-chloro-5-fluorophenyl-4-t)-4-nitrobenzo[c]...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/17/2025
Entry Details
Go to US Patent

TargetEndothelial PAS domain-containing protein 1(Human)
Novartis

US Patent
LigandPNGBDBM721016(US12226405, Example 115)
Affinity DataIC50: 3nMAssay Description:The scintillation proximal assay (SPA) was based on a competition binding assay with the radio-ligand N-(3-chloro-5-fluorophenyl-4-t)-4-nitrobenzo[c]...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/17/2025
Entry Details
Go to US Patent

TargetEndothelial PAS domain-containing protein 1(Human)
Novartis

US Patent
LigandPNGBDBM720926(US12226405, Example 23)
Affinity DataIC50: 4nMAssay Description:The scintillation proximal assay (SPA) was based on a competition binding assay with the radio-ligand N-(3-chloro-5-fluorophenyl-4-t)-4-nitrobenzo[c]...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/17/2025
Entry Details
Go to US Patent

TargetEndothelial PAS domain-containing protein 1(Human)
Novartis

US Patent
LigandPNGBDBM720988(US12226405, Example 85)
Affinity DataIC50: 4nMAssay Description:The scintillation proximal assay (SPA) was based on a competition binding assay with the radio-ligand N-(3-chloro-5-fluorophenyl-4-t)-4-nitrobenzo[c]...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/17/2025
Entry Details
Go to US Patent

TargetEndothelial PAS domain-containing protein 1(Human)
Novartis

US Patent
LigandPNGBDBM720990(US12226405, Example 88)
Affinity DataIC50: 4nMAssay Description:The scintillation proximal assay (SPA) was based on a competition binding assay with the radio-ligand N-(3-chloro-5-fluorophenyl-4-t)-4-nitrobenzo[c]...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/17/2025
Entry Details
Go to US Patent

TargetEndothelial PAS domain-containing protein 1(Human)
Novartis

US Patent
LigandPNGBDBM721002(US12226405, Example 100)
Affinity DataIC50: 4nMAssay Description:The scintillation proximal assay (SPA) was based on a competition binding assay with the radio-ligand N-(3-chloro-5-fluorophenyl-4-t)-4-nitrobenzo[c]...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/17/2025
Entry Details
Go to US Patent

TargetEndothelial PAS domain-containing protein 1(Human)
Novartis

US Patent
LigandPNGBDBM721011(US12226405, Example 109)
Affinity DataIC50: 4nMAssay Description:The scintillation proximal assay (SPA) was based on a competition binding assay with the radio-ligand N-(3-chloro-5-fluorophenyl-4-t)-4-nitrobenzo[c]...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/17/2025
Entry Details
Go to US Patent

TargetEndothelial PAS domain-containing protein 1(Human)
Novartis

US Patent
LigandPNGBDBM721014(US12226405, Example 113)
Affinity DataIC50: 4nMAssay Description:The scintillation proximal assay (SPA) was based on a competition binding assay with the radio-ligand N-(3-chloro-5-fluorophenyl-4-t)-4-nitrobenzo[c]...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/17/2025
Entry Details
Go to US Patent

TargetEndothelial PAS domain-containing protein 1(Human)
Novartis

US Patent
LigandPNGBDBM721018(US12226405, Example 117)
Affinity DataIC50: 4nMAssay Description:The scintillation proximal assay (SPA) was based on a competition binding assay with the radio-ligand N-(3-chloro-5-fluorophenyl-4-t)-4-nitrobenzo[c]...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/17/2025
Entry Details
Go to US Patent

TargetEndothelial PAS domain-containing protein 1(Human)
Novartis

US Patent
LigandPNGBDBM720916(US12226405, Example 13)
Affinity DataIC50: 5nMAssay Description:The scintillation proximal assay (SPA) was based on a competition binding assay with the radio-ligand N-(3-chloro-5-fluorophenyl-4-t)-4-nitrobenzo[c]...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/17/2025
Entry Details
Go to US Patent

TargetEndothelial PAS domain-containing protein 1(Human)
Novartis

US Patent
LigandPNGBDBM720931(US12226405, Example 28)
Affinity DataIC50: 5nMAssay Description:The scintillation proximal assay (SPA) was based on a competition binding assay with the radio-ligand N-(3-chloro-5-fluorophenyl-4-t)-4-nitrobenzo[c]...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/17/2025
Entry Details
Go to US Patent

TargetEndothelial PAS domain-containing protein 1(Human)
Novartis

US Patent
LigandPNGBDBM720982(US12226405, Example 79)
Affinity DataIC50: 5nMAssay Description:The scintillation proximal assay (SPA) was based on a competition binding assay with the radio-ligand N-(3-chloro-5-fluorophenyl-4-t)-4-nitrobenzo[c]...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/17/2025
Entry Details
Go to US Patent

TargetEndothelial PAS domain-containing protein 1(Human)
Novartis

US Patent
LigandPNGBDBM720993(US12226405, Example 91)
Affinity DataIC50: 5nMAssay Description:The scintillation proximal assay (SPA) was based on a competition binding assay with the radio-ligand N-(3-chloro-5-fluorophenyl-4-t)-4-nitrobenzo[c]...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/17/2025
Entry Details
Go to US Patent

TargetEndothelial PAS domain-containing protein 1(Human)
Novartis

US Patent
LigandPNGBDBM721006(US12226405, Example 104)
Affinity DataIC50: 5nMAssay Description:The scintillation proximal assay (SPA) was based on a competition binding assay with the radio-ligand N-(3-chloro-5-fluorophenyl-4-t)-4-nitrobenzo[c]...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/17/2025
Entry Details
Go to US Patent

TargetEndothelial PAS domain-containing protein 1(Human)
Novartis

US Patent
LigandPNGBDBM720919(US12226405, Example 16)
Affinity DataIC50: 6nMAssay Description:The scintillation proximal assay (SPA) was based on a competition binding assay with the radio-ligand N-(3-chloro-5-fluorophenyl-4-t)-4-nitrobenzo[c]...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/17/2025
Entry Details
Go to US Patent

TargetEndothelial PAS domain-containing protein 1(Human)
Novartis

US Patent
LigandPNGBDBM720921((1'S,4'S)-6'-bromo-8-(difluoromethoxy)-3',3',5'-tr...)
Affinity DataIC50: 6nMAssay Description:The scintillation proximal assay (SPA) was based on a competition binding assay with the radio-ligand N-(3-chloro-5-fluorophenyl-4-t)-4-nitrobenzo[c]...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/17/2025
Entry Details
Go to US Patent

TargetEndothelial PAS domain-containing protein 1(Human)
Novartis

US Patent
LigandPNGBDBM720929(US12226405, Example 26)
Affinity DataIC50: 6nMAssay Description:The scintillation proximal assay (SPA) was based on a competition binding assay with the radio-ligand N-(3-chloro-5-fluorophenyl-4-t)-4-nitrobenzo[c]...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/17/2025
Entry Details
Go to US Patent

TargetEndothelial PAS domain-containing protein 1(Human)
Novartis

US Patent
LigandPNGBDBM720939(US12226405, Example 36)
Affinity DataIC50: 6nMAssay Description:The scintillation proximal assay (SPA) was based on a competition binding assay with the radio-ligand N-(3-chloro-5-fluorophenyl-4-t)-4-nitrobenzo[c]...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/17/2025
Entry Details
Go to US Patent

TargetEndothelial PAS domain-containing protein 1(Human)
Novartis

US Patent
LigandPNGBDBM720942(US12226405, Example 39)
Affinity DataIC50: 6nMAssay Description:The scintillation proximal assay (SPA) was based on a competition binding assay with the radio-ligand N-(3-chloro-5-fluorophenyl-4-t)-4-nitrobenzo[c]...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/17/2025
Entry Details
Go to US Patent

TargetEndothelial PAS domain-containing protein 1(Human)
Novartis

US Patent
LigandPNGBDBM720943(US12226405, Example 40)
Affinity DataIC50: 6nMAssay Description:The scintillation proximal assay (SPA) was based on a competition binding assay with the radio-ligand N-(3-chloro-5-fluorophenyl-4-t)-4-nitrobenzo[c]...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/17/2025
Entry Details
Go to US Patent

TargetEndothelial PAS domain-containing protein 1(Human)
Novartis

US Patent
LigandPNGBDBM720963(US12226405, Example 60)
Affinity DataIC50: 6nMAssay Description:The scintillation proximal assay (SPA) was based on a competition binding assay with the radio-ligand N-(3-chloro-5-fluorophenyl-4-t)-4-nitrobenzo[c]...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/17/2025
Entry Details
Go to US Patent

TargetEndothelial PAS domain-containing protein 1(Human)
Novartis

US Patent
LigandPNGBDBM720976(US12226405, Example 73)
Affinity DataIC50: 6nMAssay Description:The scintillation proximal assay (SPA) was based on a competition binding assay with the radio-ligand N-(3-chloro-5-fluorophenyl-4-t)-4-nitrobenzo[c]...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/17/2025
Entry Details
Go to US Patent

TargetEndothelial PAS domain-containing protein 1(Human)
Novartis

US Patent
LigandPNGBDBM721017(US12226405, Example 116)
Affinity DataIC50: 6nMAssay Description:The scintillation proximal assay (SPA) was based on a competition binding assay with the radio-ligand N-(3-chloro-5-fluorophenyl-4-t)-4-nitrobenzo[c]...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/17/2025
Entry Details
Go to US Patent

TargetEndothelial PAS domain-containing protein 1(Human)
Novartis

US Patent
LigandPNGBDBM720975(US12226405, Example 72)
Affinity DataIC50: 7nMAssay Description:The scintillation proximal assay (SPA) was based on a competition binding assay with the radio-ligand N-(3-chloro-5-fluorophenyl-4-t)-4-nitrobenzo[c]...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/17/2025
Entry Details
Go to US Patent

TargetEndothelial PAS domain-containing protein 1(Human)
Novartis

US Patent
LigandPNGBDBM720991(US12226405, Example 89)
Affinity DataIC50: 7nMAssay Description:The scintillation proximal assay (SPA) was based on a competition binding assay with the radio-ligand N-(3-chloro-5-fluorophenyl-4-t)-4-nitrobenzo[c]...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/17/2025
Entry Details
Go to US Patent

TargetEndothelial PAS domain-containing protein 1(Human)
Novartis

US Patent
LigandPNGBDBM721009(US12226405, Example 107)
Affinity DataIC50: 7nMAssay Description:The scintillation proximal assay (SPA) was based on a competition binding assay with the radio-ligand N-(3-chloro-5-fluorophenyl-4-t)-4-nitrobenzo[c]...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/17/2025
Entry Details
Go to US Patent

TargetEndothelial PAS domain-containing protein 1(Human)
Novartis

US Patent
LigandPNGBDBM721013(US12226405, Example 112)
Affinity DataIC50: 7nMAssay Description:The scintillation proximal assay (SPA) was based on a competition binding assay with the radio-ligand N-(3-chloro-5-fluorophenyl-4-t)-4-nitrobenzo[c]...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/17/2025
Entry Details
Go to US Patent

TargetEndothelial PAS domain-containing protein 1(Human)
Novartis

US Patent
LigandPNGBDBM720909(US12226405, Example 6)
Affinity DataIC50: 8nMAssay Description:The scintillation proximal assay (SPA) was based on a competition binding assay with the radio-ligand N-(3-chloro-5-fluorophenyl-4-t)-4-nitrobenzo[c]...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/17/2025
Entry Details
Go to US Patent

TargetEndothelial PAS domain-containing protein 1(Human)
Novartis

US Patent
LigandPNGBDBM720915(US12226405, Example 12)
Affinity DataIC50: 8nMAssay Description:The scintillation proximal assay (SPA) was based on a competition binding assay with the radio-ligand N-(3-chloro-5-fluorophenyl-4-t)-4-nitrobenzo[c]...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/17/2025
Entry Details
Go to US Patent

TargetEndothelial PAS domain-containing protein 1(Human)
Novartis

US Patent
LigandPNGBDBM720925(US12226405, Example 22)
Affinity DataIC50: 8nMAssay Description:The scintillation proximal assay (SPA) was based on a competition binding assay with the radio-ligand N-(3-chloro-5-fluorophenyl-4-t)-4-nitrobenzo[c]...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/17/2025
Entry Details
Go to US Patent

TargetEndothelial PAS domain-containing protein 1(Human)
Novartis

US Patent
LigandPNGBDBM720932(US12226405, Example 29)
Affinity DataIC50: 8nMAssay Description:The scintillation proximal assay (SPA) was based on a competition binding assay with the radio-ligand N-(3-chloro-5-fluorophenyl-4-t)-4-nitrobenzo[c]...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/17/2025
Entry Details
Go to US Patent

TargetEndothelial PAS domain-containing protein 1(Human)
Novartis

US Patent
LigandPNGBDBM720945(US12226405, Example 42)
Affinity DataIC50: 8nMAssay Description:The scintillation proximal assay (SPA) was based on a competition binding assay with the radio-ligand N-(3-chloro-5-fluorophenyl-4-t)-4-nitrobenzo[c]...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/17/2025
Entry Details
Go to US Patent

TargetEndothelial PAS domain-containing protein 1(Human)
Novartis

US Patent
LigandPNGBDBM720961(US12226405, Example 58)
Affinity DataIC50: 8nMAssay Description:The scintillation proximal assay (SPA) was based on a competition binding assay with the radio-ligand N-(3-chloro-5-fluorophenyl-4-t)-4-nitrobenzo[c]...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/17/2025
Entry Details
Go to US Patent

TargetEndothelial PAS domain-containing protein 1(Human)
Novartis

US Patent
LigandPNGBDBM720969(US12226405, Example 66)
Affinity DataIC50: 8nMAssay Description:The scintillation proximal assay (SPA) was based on a competition binding assay with the radio-ligand N-(3-chloro-5-fluorophenyl-4-t)-4-nitrobenzo[c]...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/17/2025
Entry Details
Go to US Patent

TargetEndothelial PAS domain-containing protein 1(Human)
Novartis

US Patent
LigandPNGBDBM720981(US12226405, Example 78)
Affinity DataIC50: 8nMAssay Description:The scintillation proximal assay (SPA) was based on a competition binding assay with the radio-ligand N-(3-chloro-5-fluorophenyl-4-t)-4-nitrobenzo[c]...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/17/2025
Entry Details
Go to US Patent

TargetEndothelial PAS domain-containing protein 1(Human)
Novartis

US Patent
LigandPNGBDBM720907(US12226405, Example 4)
Affinity DataIC50: 9nMAssay Description:The scintillation proximal assay (SPA) was based on a competition binding assay with the radio-ligand N-(3-chloro-5-fluorophenyl-4-t)-4-nitrobenzo[c]...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/17/2025
Entry Details
Go to US Patent

TargetEndothelial PAS domain-containing protein 1(Human)
Novartis

US Patent
LigandPNGBDBM720908(US12226405, Example 5)
Affinity DataIC50: 9nMAssay Description:The scintillation proximal assay (SPA) was based on a competition binding assay with the radio-ligand N-(3-chloro-5-fluorophenyl-4-t)-4-nitrobenzo[c]...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/17/2025
Entry Details
Go to US Patent

TargetEndothelial PAS domain-containing protein 1(Human)
Novartis

US Patent
LigandPNGBDBM720917(US12226405, Example 14)
Affinity DataIC50: 9nMAssay Description:The scintillation proximal assay (SPA) was based on a competition binding assay with the radio-ligand N-(3-chloro-5-fluorophenyl-4-t)-4-nitrobenzo[c]...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/17/2025
Entry Details
Go to US Patent

TargetEndothelial PAS domain-containing protein 1(Human)
Novartis

US Patent
LigandPNGBDBM720934(US12226405, Example 31)
Affinity DataIC50: 9nMAssay Description:The scintillation proximal assay (SPA) was based on a competition binding assay with the radio-ligand N-(3-chloro-5-fluorophenyl-4-t)-4-nitrobenzo[c]...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/17/2025
Entry Details
Go to US Patent

TargetEndothelial PAS domain-containing protein 1(Human)
Novartis

US Patent
LigandPNGBDBM720938(US12226405, Example 35)
Affinity DataIC50: 9nMAssay Description:The scintillation proximal assay (SPA) was based on a competition binding assay with the radio-ligand N-(3-chloro-5-fluorophenyl-4-t)-4-nitrobenzo[c]...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/17/2025
Entry Details
Go to US Patent

TargetEndothelial PAS domain-containing protein 1(Human)
Novartis

US Patent
LigandPNGBDBM720954(US12226405, Example 51)
Affinity DataIC50: 9nMAssay Description:The scintillation proximal assay (SPA) was based on a competition binding assay with the radio-ligand N-(3-chloro-5-fluorophenyl-4-t)-4-nitrobenzo[c]...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/17/2025
Entry Details
Go to US Patent

TargetEndothelial PAS domain-containing protein 1(Human)
Novartis

US Patent
LigandPNGBDBM720958(US12226405, Example 55)
Affinity DataIC50: 9nMAssay Description:The scintillation proximal assay (SPA) was based on a competition binding assay with the radio-ligand N-(3-chloro-5-fluorophenyl-4-t)-4-nitrobenzo[c]...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/17/2025
Entry Details
Go to US Patent

TargetEndothelial PAS domain-containing protein 1(Human)
Novartis

US Patent
LigandPNGBDBM720972(US12226405, Example 69)
Affinity DataIC50: 9nMAssay Description:The scintillation proximal assay (SPA) was based on a competition binding assay with the radio-ligand N-(3-chloro-5-fluorophenyl-4-t)-4-nitrobenzo[c]...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/17/2025
Entry Details
Go to US Patent

TargetEndothelial PAS domain-containing protein 1(Human)
Novartis

US Patent
LigandPNGBDBM720986(US12226405, Example 83)
Affinity DataIC50: 9nMAssay Description:The scintillation proximal assay (SPA) was based on a competition binding assay with the radio-ligand N-(3-chloro-5-fluorophenyl-4-t)-4-nitrobenzo[c]...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/17/2025
Entry Details
Go to US Patent

Displayed 1 to 50 (of 117 total ) | Next | Last >>
Jump to: